Company ProfilePremium

Ginkgo Bioworks

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Ginkgo Bioworks - Healthcare showcase

Year Founded & Workforce

2008

300 Employees

Industry

Healthcare

Services

Nanobots
G

Ginkgo Bioworks Employee Contacts

92 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Ginkgo Bioworks Overview

Company Headquarters: Boston, US

Founded: 2008

Workforce: ~300+

Company Working: Ginkgo Bioworks is one of the renowned companies in the life sciences industry. Over the past decade, the particular focus of the company has been on offering innovative solutions in the field of biotechnology, including the development and manufacturing of cultured ingredients, biological engineering, metabolic engineering, and genetically modified organisms. Recently, Ginkgo Bioworks raised more than USD 350 million and with this the company’s valuation crossed USD 4000 million. Ginkgo Bioworks conducts its manufacturing activities through four facilities located in the US.

Strategy

Ginkgo Bioworks is focusing on delivering innovative solutions and enhancing product quality through research and development. The company also emphasizes product launches and increasing its product reach by collaborations with distributors. The company has maintained its own codebase of cells, enzymes, and genetic programs, which helps in the manufacturing process and to deliver effective solutions.

Company Snapshot

300

Employees

2008

Founded

Boston, US

Headquarters

SWOT Analysis

Strengths

  • Wide geographic presence
  • High focus on R&D
  • Portfolio comprises innovative products
  • Large production capacity

Weaknesses

  • Portfolio limited to the life sciences segment

Opportunities

  • Collaborations and joint ventures

Threats

  • Stringent regulations regarding product approvals

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
May 2019AcquisitionGinkgo Bioworks announced the acquisition of Warp Drive Bio, well known for genome mining, for an undisclosed amount. This acquisition will enhance R&D in the development of platforms for use in next-generation antibiotics.
January 2017AcquisitionGinkgo Bioworks acquired synthetic DNA provider Gen9 by an undisclosed acquisition deal. This approach has helped to increase the speed and capacity of the manufacturing activities and construction of new organisms.

Product Offering

  • Ginkgo Bioworks
    • Nanobots

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.